ClinicalTrials.gg
Not yet recruitingNCT07809386Updated Sep 9, 2026

The Effect of Gamified Sleep Hygiene Education on Sleep Quality and Fatigue Levels in Chemotherapy Patients

An interventional study of Gamified Sleep Hygiene Education and Standard Sleep Hygiene Education in Cancer, sponsored by Lokman Hekim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-09.

Sponsored by Lokman Hekim University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Sleep disturbances and fatigue are common problems among patients receiving chemotherapy and may negatively affect their quality of life. This randomized controlled trial aims to evaluate the effect of gamified sleep hygiene education on sleep quality and cancer-related fatigue in patients receiving chemotherapy.

A total of 56 patients will be randomly assigned to two groups, with 28 participants in each group. The intervention group will receive gamified sleep hygiene education through the web-based "Sleep Hunter" program, while the active comparator group will receive standard sleep hygiene education through verbal instruction and educational brochures. The intervention will be delivered in two sessions over a two-week period.

Sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire, and cancer-related fatigue will be assessed using the Hirai Cancer Fatigue Scale. Outcomes will be assessed at baseline and after completion of the two-week intervention.

02

Conditions studied

  • Cancer

Keywords

  • Chemotherapy
  • Gamification
  • Sleep Hygiene
  • Sleep Quality
  • Cancer-Related Fatigue
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's planned enrollment of 56 is close to the median of 60 across 7,703 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Lokman Hekim University is the lead sponsor of 43 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Currently receiving chemotherapy
  • Able to read and write in Turkish
  • Able to communicate effectively
  • Able to use a smartphone or tablet and access the web-based educational intervention
  • No previous diagnosis of a sleep disorder
  • No previous treatment for a sleep disorder
  • Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  • Presence of a major mental disorder that may interfere with participation in the study
  • Presence of a major visual, hearing, or communication impairment that may interfere with participation in the study
  • Unable to read or write in Turkish
  • Unable to use a smartphone or tablet or access the web-based educational intervention
  • Previous diagnosis of a sleep disorder
  • Previous treatment for a sleep disorder
  • Unwilling to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Active comparator
    Standard Sleep Hygiene Education Group

    Participants in the control group will receive standard sleep hygiene education through verbal instruction and educational brochures in two sessions. Post-intervention assessments will be performed following completion of the education.

    Behavioral: Standard Sleep Hygiene Education

  • Experimental
    Gamified Sleep Hygiene Education Group

    Participants in the intervention group will receive gamified sleep hygiene education using the web-based "Sleep Hunter" educational material. The intervention will be delivered over a two-week period. The gamified education includes sleep hygiene content presented through an online escape-room format incorporating educational videos, audio narrations, visuals, animations, matching activities, fill-in-the-blank activities, and true/false questions

    Behavioral: Gamified Sleep Hygiene Education

Interventions

  • BehavioralGamified Sleep Hygiene Education

    Gamified sleep hygiene education will be delivered using the web-based "Sleep Hunter" educational material developed in an online escape-room format. The educational content includes sleep hygiene, stimulus control, caffeine use, screen light exposure, regulation of the sleep environment, relaxation exercises, breathing techniques, and establishment of a sleep routine. The program incorporates gamification elements including badges, levels, rewards, educational videos, audio narrations, visuals, animations, matching activities, fill-in-the-blank activities, and true/false questions. The intervention will be delivered using smartphones or tablets in two sessions over a two-week period. Each session will last no longer than 10 minutes, with a total education duration of approximately 20 minutes.

  • BehavioralStandard Sleep Hygiene Education

    Standard sleep hygiene education will be provided through verbal instruction and educational brochures in two sessions.

06

What researchers measure

Primary outcomes

  1. Change in Richards-Campbell Sleep Questionnaire Total Score

    Sleep quality will be measured using the Richards-Campbell Sleep Questionnaire (RCSQ). The RCSQ yields a total score ranging from 0 to 100, with higher scores indicating better perceived sleep quality. The outcome will be the change in the RCSQ total score from baseline to the end of the 2-week intervention.

    Time frame: Baseline and immediately after completion of the 2-week intervention

Secondary outcomes

  1. Change in Hirai Cancer Fatigue Scale Total Score

    Cancer-related fatigue will be measured using the Hirai Cancer Fatigue Scale. The scale consists of 15 items and yields a total score ranging from 15 to 75, with higher scores indicating greater cancer-related fatigue. The outcome will be the change in the total score from baseline to the end of the 2-week intervention.

    Time frame: Baseline and immediately after completion of the 2-week intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared to protect participant confidentiality and privacy. Aggregated study results will be reported in scientific publications and presentations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07809386
Lead sponsor
Lokman Hekim University
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Esra Turker (Associate Professor, Lokman Hekim University) — Principal investigator
First posted
Sep 9, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Sep 9, 2026

Study contacts

Esra Türker, Assoc. Prof.
Contact
esra.turker@lokmanhekim.edu.tr
+905074521224

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion